No connection

Search Results

NVST vs OPCH

NVST
Envista Holdings Corporation
NEUTRAL
Price
$25.94
Market Cap
$4.23B
Sector
Healthcare
AI Confidence
80%
OPCH
Option Care Health, Inc.
NEUTRAL
Price
$26.87
Market Cap
$4.2B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
NVST
92.64
OPCH
21.16
Forward P/E
NVST
16.64
OPCH
12.63
P/B Ratio
NVST
1.37
OPCH
3.18
P/S Ratio
NVST
1.55
OPCH
0.74
EV/EBITDA
NVST
12.83
OPCH
12.82

Profitability

Gross Margin
NVST
55.02%
OPCH
19.26%
Operating Margin
NVST
10.74%
OPCH
6.24%
Profit Margin
NVST
1.73%
OPCH
3.67%
ROE
NVST
1.56%
OPCH
15.2%
ROA
NVST
2.78%
OPCH
6.14%

Growth

Revenue Growth
NVST
15.0%
OPCH
8.8%
Earnings Growth
NVST
3146.1%
OPCH
1.3%

Financial Health

Debt/Equity
NVST
0.51
OPCH
0.96
Current Ratio
NVST
2.38
OPCH
1.52
Quick Ratio
NVST
1.93
OPCH
0.9

Dividends

Dividend Yield
NVST
--
OPCH
--
Payout Ratio
NVST
0.0%
OPCH
0.0%

AI Verdict

NVST NEUTRAL

NVST presents a complex profile with a stable Piotroski F-Score of 4/9 and a significant valuation gap, as the current price of $25.94 far exceeds the Graham Number ($10.93) and Intrinsic Value ($8.26). While the company shows strong short-term price momentum (+61.3% 1Y) and a highly attractive Forward P/E of 16.64, its trailing P/E of 92.64 and razor-thin profit margin of 1.73% indicate a precarious transition period. The bullish analyst consensus is countered by bearish insider sentiment and a 0/100 technical trend, suggesting the market is pricing in a recovery that has not yet fully materialized in the fundamentals.

Strengths
Strong liquidity with a Current Ratio of 2.38 and Quick Ratio of 1.93
Healthy Gross Margin of 55.02% indicating strong product pricing power
Manageable leverage with a Debt/Equity ratio of 0.51
Risks
Severe overvaluation relative to defensive metrics (Graham Number $10.93)
Extremely low net profit margin (1.73%) leaving little room for error
Bearish insider activity and technical trends
OPCH NEUTRAL

OPCH exhibits strong operational health with a Piotroski F-Score of 7/9, indicating a robust financial foundation. However, there is a severe disconnect between the current market price ($26.87) and deterministic value metrics, with the Graham Number ($15.54) and Intrinsic Value ($11.37) suggesting significant overvaluation. While analysts remain aggressively bullish with a $40.09 target, this is contradicted by bearish insider selling and a 0/100 technical trend. The stock appears to be a high-quality business trading at a speculative premium.

Strengths
Strong Piotroski F-Score (7/9) indicating high financial health
Healthy Return on Equity (ROE) of 15.20%
Low Price-to-Sales ratio (0.74) suggesting efficient revenue valuation
Risks
Significant premium to Graham Number and Intrinsic Value
Bearish insider sentiment with net selling activity
Negative technical trend (0/100) and 1-year price decline of 12.4%

Compare Another Pair

NVST vs OPCH: Head-to-Head Comparison

This page compares Envista Holdings Corporation (NVST) and Option Care Health, Inc. (OPCH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile